Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava (Q44440454)

3 December 2017

Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava (English)

1 reference

3 December 2017

0 references

1 reference

1 reference

phlorofucofuroeckol A

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

Ji-Young Park

1

1 reference

3 December 2017

Jang Hoon Kim

2

1 reference

3 December 2017

Jung Min Kwon

3

1 reference

3 December 2017

Hyung-Jun Kwon

4

1 reference

3 December 2017

Hyung Jae Jeong

5

1 reference

3 December 2017

Young Min Kim

6

1 reference

3 December 2017

Doman Kim

7

1 reference

3 December 2017

Woo Song Lee

8

1 reference

3 December 2017

Young Bae Ryu

9

1 reference

3 December 2017

language of work or name

English

0 references

publication date

22 April 2013

1 reference

full work available at URL

3 December 2017

https://europepmc.org/articles/pmc7126891?pdf=render

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1016/j.bmc.2013.04.026?email=unpaywall_01@example.com

published in

Bioorganic & Medicinal Chemistry

1 reference

3 December 2017

21

1 reference

3 December 2017

3730-3737

1 reference

3 December 2017

13

1 reference

https://api.unpaywall.org/v2/10.1016/j.bmc.2013.04.026?email=unpaywall_01@example.com

3 December 2017

1 reference

19 March 2024

access restriction status

open access

1 reference

inferred from online access status

cites work

Protective effects of enzymatic digest from Ecklonia cava against high glucose-induced oxidative stress in human umbilical vein endothelial cells

1 reference

12 December 2020

Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles.

1 reference

12 December 2020

Influenza virus neuraminidase inhibitory activity of phlorotannins from the edible brown alga Ecklonia cava

1 reference

12 December 2020

Small molecules targeting severe acute respiratory syndrome human coronavirus

1 reference

12 December 2020

Inhibitory effects and molecular mechanism of dieckol isolated from marine brown alga on COX-2 and iNOS in microglial cells

1 reference

12 December 2020

Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease

1 reference

12 December 2020

Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.

1 reference

12 December 2020

Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds.

1 reference

12 December 2020

SARS--beginning to understand a new virus

1 reference

12 December 2020

Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.

1 reference

12 December 2020

Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity

1 reference

12 December 2020

Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Anti-inflammatory phloroglucinol derivatives from Hypericum empetrifolium

1 reference

12 December 2020

Reduced surface: an efficient way to compute molecular surfaces

1 reference

12 December 2020

Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus

1 reference

12 December 2020

Molecular biology of severe acute respiratory syndrome coronavirus

1 reference

12 December 2020

Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds

1 reference

12 December 2020

Antibacterial activity of Ecklonia cava against methicillin-resistant Staphylococcus aureus and Salmonella spp.

1 reference

12 December 2020

Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases.

1 reference

12 December 2020

Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs

1 reference

12 December 2020

Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus.

1 reference

12 December 2020

Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition

1 reference

12 December 2020

Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-κB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages

1 reference

12 December 2020

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

1 reference

12 December 2020

SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii

1 reference

12 December 2020

Identification of a new cleavage site of the 3C-like protease of rabbit haemorrhagic disease virus

1 reference

12 December 2020

Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus

1 reference

12 December 2020

Inhibitory effect of phlorotannins isolated from Ecklonia cava on mushroom tyrosinase activity and melanin formation in mouse B16F10 melanoma cells

1 reference

12 December 2020

Development of antiviral therapy for severe acute respiratory syndrome.

1 reference

12 December 2020

10.1016/J.BMC.2013.04.026

Identifiers

DOI

1 reference

3 December 2017

0 references

0 references

1 reference